Match!
S. Djalalov
Westminster International University in Tashkent
21Publications
4H-index
136Citations
Publications 21
Newest
#1S. Djalalov (Westminster International University in Tashkent)H-Index: 4
Last.Jeffrey S. Hoch (UC Davis: University of California, Davis)H-Index: 31
view all 5 authors...
Abstract Background There is an increasing number of Russian economic evaluation studies in oncology, the scope and quality of which are unknown. Objectives This study aimed to assess the scope and quality of economic evaluations in oncology, with the goal of elucidating implications for improving their use in Russia. Methods Online databases were searched for oncologic economic evaluations written in Russian. Data were extracted and assessed with the Quality of Health Economic Studies (QHES) in...
#1S. DjalalovH-Index: 4
#2Lisa Masucci (St. Michael's Hospital)H-Index: 2
Last.Jeffrey S. Hoch (UC Davis: University of California, Davis)H-Index: 31
view all 11 authors...
#1S. Djalalov (St. Michael's Hospital)H-Index: 4
#2J. Beca (St. Michael's Hospital)H-Index: 8
Last.Jeffrey S. Hoch (St. Michael's Hospital)H-Index: 31
view all 6 authors...
Background Aromatase inhibitor (ai) therapy has been subjected to numerous cost-effectiveness analyses. However, with most ais having reached the end of patent protection and with maturation of the clinical trials data, a re-analysis of ai cost-effectiveness and a consideration of ai use as part of sequential therapy is desirable. Our objective was to assess the cost-effectiveness of the 5-year upfront and sequential tamoxifen (tam) and ai hormonal strategies currently used for treating patients...
#1S. Djalalov (St. Michael's Hospital)H-Index: 4
#2Donna M. GrahamH-Index: 4
Last.Natasha B. Leighl (OICR: Ontario Institute for Cancer Research)H-Index: 48
view all 6 authors...
#1S. Djalalov (St. Michael's Hospital)H-Index: 4
#2Linda Rabeneck (U of T: University of Toronto)H-Index: 53
Last.Jeffrey S. Hoch (U of T: University of Toronto)H-Index: 31
view all 6 authors...
Objective. To perform a systematic review of utility weights for colorectal cancer (CRC) health states reported in the scientific literature and to determine the effects of disease factors, patient characteristics, and utility methods on utility values. Methods. We identified 26 articles written in English and published from January 1980 to January 2013, providing 351 unique utilities for CRC health states elicited from 6546 unique respondents. The CRC utility data were analyzed using linear mix...
#1S. Djalalov (St. Michael's Hospital)H-Index: 4
#2Donna M. GrahamH-Index: 4
Last.Natasha B. Leighl (OICR: Ontario Institute for Cancer Research)H-Index: 48
view all 7 authors...
#1S. Djalalov (U of T: University of Toronto)H-Index: 4
#2J. Beca (U of T: University of Toronto)H-Index: 8
Last.Natasha B. Leighl (UHN: University Health Network)H-Index: 48
view all 7 authors...
Purpose ALK-targeted therapy with crizotinib offers significant improvement in clinical outcomes for the treatment of EML4-ALK fusion–positive non–small-cell lung cancer (NSCLC). We estimated the cost effectiveness of EML4-ALK fusion testing in combination with targeted first-line crizotinib treatment in Ontario. Patients and Methods A cost-effectiveness analysis was conducted using a Markov model from the Canadian Public health (Ontario) perspective and a lifetime horizon in patients with stage...
123